Related Experiment Videos
[Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses]
Huan-zhong Shi1, Qing-li Yang, Xiao-yun Mo
1Medical Centre of Respiratory and Critical disease care, First Affiliated Hospital, Guangxi Medical University, Nanning 530021, China.
Zhonghua Yi Xue Za Zhi
|January 15, 2004
Summary
Airway eosinophils act as antigen-presenting cells, stimulating T helper 2 (Th2) cell expansion. This study demonstrates eosinophils
Area of Science:
- Immunology
- Cell Biology
- Respiratory Medicine
Context:
- Eosinophils are key players in allergic inflammation.
- Their role in antigen presentation and T helper cell modulation is under investigation.
- Understanding eosinophil function is crucial for developing targeted therapies for allergic airway diseases.
Purpose:
- To investigate the capacity of airway eosinophils to present antigens and stimulate T helper 2 (Th2) cell expansion.
- To determine if eosinophils function as antigen-presenting cells (APCs) in vitro and in vivo.
- To elucidate the co-stimulatory molecule dependence (CD80/CD86) of eosinophil-mediated Th2 cell activation.
Summary:
- Airway eosinophils from ovalbumin-challenged mice presented antigens in vitro, stimulating CD4(+) T cells to produce Th2 cytokines (IL-4, IL-5, IL-13) in a CD80/CD86-dependent manner.
- Intratracheal instillation of antigen-loaded eosinophils into recipient mice led to Th2 cell priming in draining lymph nodes, confirmed by cytokine production.
- These findings establish eosinophils as functional APCs that amplify Th2 immune responses.
Impact:
- Eosinophils possess a dual role, acting not only as effector cells but also as modulators of immune responses.
- This research highlights eosinophils' potential to amplify Th2 cell responses, offering new insights into allergic airway disease pathogenesis.
- The findings suggest novel therapeutic strategies targeting eosinophil antigen presentation to control Th2-mediated inflammation.